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Immunohistochemical Evidence of Seizure-Induced Activation
of trkB Receptors in the Mossy Fiber Pathway of Adult
Mouse Hippocampus
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Genetic and pharmacological perturbations suggest that ty-
rosine receptor kinase B (trkB) receptor activation promotes
limbic epileptogenesis, but whether or where trkB activation
occurs during epileptogenesis is uncertain. Because activation
of trk receptors involves phosphorylation of specific tyrosine
residues (Segal et al., 1996), the availability of antibodies that
selectively recognize the phosphorylated form of trk receptors at
the Shc site permits an immunohistochemical assessment of trk
receptor activation. We reported previously increased phospho-
specific trk (p-trk) immunoreactivity in the mossy fiber pathway
of the hippocampus during epileptogenesis in rats (Binder et al.,
1999b). Because the p-trk antibody does not distinguish among
trkA, trkB, and trkC, the identity of the neurotrophin receptor(s)
undergoing phosphorylation was uncertain. The development
of mice carrying a point mutation of the Shc binding site
(Y515F) in the trkB gene (trkBshc) provided an opportunity to
test the hypothesis that trkB is the neurotrophin receptor un-
dergoing phosphorylation. Epileptogenesis in wild-type (WT)
mice was associated with increased p-trk immunoreactivity in
both the mossy fiber pathway and CA3 stratum oriens of hip-
pocampus. In contrast, the epileptogenesis-associated in-
crease of p-trk immunoreactivity was reduced in trkBshc mutant
mice. The development of epileptogenesis as measured by
electrophysiological and behavioral indices did not differ be-
tween trkBshc mutant and WT mice. These data demonstrate
that the neurotrophin receptor trkB undergoes phosphorylation
in the mossy fiber pathway and CA3 stratum oriens of the
hippocampus during limbic epileptogenesis. In addition, the
signaling pathways activated by the Shc site of trkB exert no
detectable regulatory effects on limbic epileptogenesis.
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Elucidating the mechanisms of limbic epileptogenesis in cellular
and molecular terms may provide novel therapeutic approaches to
prevent the disease. In the kindling model, repeated induction of
brief, focal seizures by application of initially subconvulsive elec-
trical stimuli eventually results in intense focal and tonic–clonic
seizures (Goddard et al., 1969). Once established, the enhanced
sensitivity to electrical stimulation is lifelong. The cellular and
molecular events by which seizures beget more intense seizures
are incompletely understood. The idea emerged that extracellular
signaling molecules might be pivotal in the transduction process.
Two criteria for candidate signals emerged: that seizure activity
regulates the production and release of the molecules and that the
molecules effect structural and functional changes that could
result in hyperexcitability. One class of molecules that met these
criteria was the neurotrophins, in particular brain-derived neuro-
trophic factor (BDNF) and its cognate tyrosine kinase receptor
trkB. Limbic seizures increase the mRNA content of BDNF in
multiple neuronal populations of forebrain (Isackson et al., 1991).
The development of kindling is inhibited in mice heterozygous
for BDNF (Kokaia et al., 1995). Intraventricular infusion of trk
receptor bodies sequester and limit the action of distinct neuro-
trophins; infusion of trkB-Fc inhibited epileptogenesis, whereas
infusion of trkA-Fc or trkC-Fc did not (Binder et al., 1999a). The
occurrence of epileptiform spiking on electroencephalogram
(EEG) long after kainate-induced status epilepticus is impaired
in transgenic mice overexpressing truncated trkB, presumably by
limiting activation of trkB (La¨hteinen et al., 2002). Finally, al-
though conflicting results emerged from intracerebral infusions of
BDNF (Larmet et al., 1995; Scharfman et al., 2002), transgenic
mice overexpressing BDNF exhibit an enhanced response to
epileptogenic stimuli (Croll et al., 1999).
Together with the seizure-induced expression of BDNF, these
findings led to the hypothesis that enhanced activation of trkB
occurs in the hippocampus during limbic epileptogenesis. Be-
cause activation of trk receptors involves phosphorylation of
specific tyrosine residues (Schlessinger and Ullrich, 1992; Segal
and Greenberg, 1996), the availability of antibodies that selec-
tively recognize the phosphorylated form of trk receptors (Segal
et al., 1996) permits immunohistochemical assessment of trk
receptor activation. We reported increased phospho-specific trk
immunoreactivity (p-trk IR) in the hippocampal mossy fiber
pathway during epileptogenesis in rats (Binder et al., 1999b).
Because the p-trk antibody does not distinguish among trkA,
trkB, and trkC, the precise neurotrophin receptor(s) undergoing
phosphorylation was uncertain. The temporal and spatial concor-
dance of seizure-induced increases of p-trk immunoreactivity and
BDNF protein suggested that increased phosphorylation of trkB
was responsible for the increased p-trk immunoreactivity. The
development of mice carrying a point mutation of the Shc binding
site in the trkB gene (trkBshc mutant mice) permitted testing this
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hypothesis. That is, substitution of phenylalanine for tyrosine at
residue 515 of trkB (Y515F) eliminates the binding site for the
phospho-trk antibody in trkB but not trkA or trkC. This mutation
of trkB disrupts the binding of Shc adaptor protein to trkB and
abolishes Shc site-mediated downstream signaling events
(Minichiello et al., 1998). If our hypothesis is correct, induction of
epileptogenesis should produce increased phospho-trk immuno-
reactivity in the mossy fiber pathway of wild-type (WT) but not
trkBshc mutant mice.
MATERIALS AND METHODS
Mice. trkB shc mutant mice were generated as described previously
(Minichiello et al., 1998). In brief, PCR-aided mutagenesis was used to
introduce a single point mutation (A to T, position 2055) in trkB receptor
that resulted in a change of tyrosine 515 into phenylalanine (Y515F).
Nonphosphorylatable F515 disrupted the binding of adaptor proteins to
the Shc site in trkB and abolished Shc site-mediated down-stream sig-
naling events. The amount of autophosphorylated trkB was reduced in
trkB shc/shc neurons after BDNF or neurotrophin-4 (NT-4) stimulation. In
the present study, the genotype of each animal was assessed twice using
PCR of genomic DNA isolated from tail (before experiment) and liver
(after being killed). Nine wild-type (/), 14 heterozygous (/), and
13 homozygous (/) trkB shc mice (20–35 gm) were used in this
experiment.
Antibody. A peptide affinity-purified polyclonal trk antibody (pY490)
(New England Biolabs, Beverly, MA) directed against a synthetic
phospho-tyr 490 peptide corresponding to residues 485–493
(IENPQY*FSD) of human trkA was used for immunohistochemistry as
we described previously (Binder et al., 1999b). The sequence of this
peptide is highly conserved among trkA, trkB, and trkC receptors and
also among human, rat, and mouse. Antibody pY490 is phospho-specific,
recognizing the phosphorylated but not the nonphosphorylated form of
peptide 490. Additionally, pY490 is phosphorylation site specific, recog-
nizing phosphorylated 490 but not a trk peptide phosphorylated at
residues 674/675 (Binder et al., 1999b).
Surgery and kindling. Under pentobarbital anesthesia (60 mg/kg, i.p.),
a stimulation–recording bipolar electrode was stereotactically implanted
in the right amygdala using the following coordinates, with bregma as the
reference: 1.0 mm posterior, 2.9 mm lateral, and 4.6 mm below dura. A
wire secured to the skull overlying the left frontal cortex was used as the
ground electrode. After a postoperative recovery period of at least 1
week, the electrographic seizure threshold (EST) was determined by
application of 1 sec train of 1 msec biphasic rectangular pulses at 60 Hz
beginning at 60 A; additional stimulations increasing by 20 A were
administered at 1 min intervals until an electrographic seizure lasting at
least 5 sec was detected on the EEG recorded from the amygdala.
Subsequently, experimental animals were stimulated twice each day at a
stimulus intensity 100 A above the EST, with an interstimulus interval
of at least 4 hr until three consecutive seizures of class 4 or greater with
limb clonus and/or tonus lasting at least 12 sec were evoked. The
behavioral manifestations of seizures were classified according to a
modification of Racine’s classification (Racine, 1972): 1, facial clonus; 2,
head nodding; 3, unilateral forelimb clonus; 4, rearing with bilateral
forelimb clonus; 5, rearing and falling (loss of postural control); 6,
running or bouncing seizures; and 7, tonic hindlimb extension. The
surgery and kindling procedures were performed by an individual
blinded to genotype of the animals. Control animals included unim-
planted as well as implanted but unstimulated mice.
Perfusion and histology. After completion of kindling and a subsequent
stimulation-free period of 2 weeks, the persistence of the hyperexcitabil-
ity was determined by administration of an additional stimulation of the
same intensity used in kindling procedure. Twenty-four hours after
stimulation, the experimental and control animals were perfused tran-
scardially under pentobarbital anesthesia with ice-cold 4% paraformal-
dehyde in 1 PBS containing 1 mM sodium orthovanadate (PBSV) for 5
min at a flow rate 7.5 ml/min. The brains were removed, postfixed in the
same solution overnight at 4°C, and cryoprotected in 20% sucrose in 1
PBSV until they sank. Coronal sections of 40 m were cut in a cryostat
at20°C, and two sections per slide were mounted in PBSV on slides, air
dried, frozen, and stored at 70°C until use. The sections were stained
with methyl green pyronine-Y for determination of electrode placement.
Only animals with correct electrode placement in the amygdaloid com-
plex were included in the statistical analysis.
Phospho-trk immunohistochemistry. To facilitate quantitative compar-
isons, slide-mounted sections isolated from stimulated and unstimulated
animals of all three genotypes (WT, heterozygotes, and homozygotes)
were processed in batches using the identical solutions and durations of
incubations, washes, etc. Antibody pY490 was used to detect the phos-
phorylated form of trk receptor using the protocol described in detail
previously (Binder et al., 1999b). Briefly, after quenching of endogenous
peroxidase activity with 0.3% H2O2/MeOH for 30 min, sections were
blocked and permeabilized in 5% normal goat serum (NGS) and 0.5%
NP-40 in 1 PBSV for 1 hr. The primary antibody, pY490 (1:10 in 1
PBSV and 5% NGS), was incubated with sections and covered by cov-
erslips in a humidified chamber at room temperature for 1 hr. The
sections were subsequently incubated in biotin-conjugated goat anti-
rabbit IgG (1:100 in PBSV and 5% NGS; Jackson ImmunoResearch,
West Grove, PA) for 1 hr. The ABC method (1:100 in PBSV with 5%
NGS, applied twice; Vectastain Elite; Vector Laboratories, Burlingame,
CA) was used for detection of immunoreactivity. Biotinyl tyramide
(1:100 in PBSV with 5% NGS, applied between two ABC incubations;
Bio-Rad, Richmond, CA) was used to enhance detection of the immu-
noreactivity. The sections were preincubated with DAB solution (Sigma
Fast; Sigma, St. Louis, MO) containing 0.04% nickel ammonium sulfate
for 15 min and then developed for 10–30 min in the same DAB solution
but also containing 0.03% H2O2. The slides were rinsed in PBS, dehy-
drated in ethanol, cleared in xylene, and coverslipped. The slides were
subsequently coded and analyzed blinded.
Peptide competition. The immunogen of antibody pY490 (phosphopep-
tide 490) and the unphosphorylated form of the same peptide were used
for peptide competition. For other controls, four additional peptides of
trkA, the phospho- and unphospho-peptides of sites 674/675 and 785,
respectively (New England Biolabs), were included in the experiments.
Each peptide used at 300 nM was incubated at room temperature with the
primary antibody solution (1:10 in PBSV with 5% NGS) for 30 min to 1
hr. After slides were quenched, blocked, and permeabilized, the primary
antibody solution coincubated with the relevant peptide was applied to
the sections. The remaining steps followed the standard protocol of
phospho-trk immunohistochemistry.
Densitometry quantification. Images of the immunoreactivity in the
CA3 and dentate gyrus (DG) of hippocampus were captured using a
high-resolution CCD camera interfaced with a light microscope (Axio-
vert 135; Zeiss, Oberkochen, Germany) and measured using a computer-
assisted image analyzer (MetaMorph 3D; Universal Imaging, West
Chester, PA). For densitometric analysis, a square box of fixed size was
placed in distinct regions within CA3 and dentate gyrus to measure the
average gray value for each location. For CA3, the gray value was
measured in three locations: strata radiatum, lucidum, and oriens. For
dentate gyrus, gray values were measured in five locations: outer molec-
ular layer (OML), middle molecular layer (MML), inner molecular layer
(IML), hilar border with granule cell layer (hilus-GCL border), and deep
hilus at the midpoint of granule cell layer (see Fig. 3). Because the corpus
callosum had less variation and a higher gray value reflecting less immu-
noreactivity, it was chosen as the reference. The results from measured
locations are presented as the percentage of reduction in gray value
compared with corpus callosum, a greater reduction in gray value reflect-
ing more phospho-trk immunoreactivity. The data for each animal are
expressed as the average from four hippocampi (one slide per animal
containing two sections, each with two hippocampi). All results were
analyzed by one-way ANOVA.
RESULTS
Increased p-trk IR in WT mice after kindling
Our recent studies provided immunohistochemical evidence that
trk receptors undergo phosphorylation in a spatially specific pat-
tern in the hippocampus during the development of kindling of
rats (Binder et al., 1999b). To determine whether trk receptor
phosphorylation also occurs in mice, p-trk immunohistochemistry
was performed in wild-type mice killed 24 hr after the last seizure
evoked by stimulation of the right amygdala. A spatially selective
increase of p-trk IR in the hippocampal formation was detected in
each of the four stimulated WT mice compared with unstimu-
lated WT mice (Fig. 1, compare A, B, arrows). The increased
immunoreactivity was evident in the hippocampal formation bi-
laterally, mainly in the mossy fiber pathway. In addition, a mod-
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erately high level but more diffuse pattern of p-trk IR was appar-
ent throughout stratum oriens of CA3. In contrast, no overt
changes of p-trk IR were evident in CA1, in stratum radiatum of
CA3, or in the molecular layer of the dentate gyrus. Quantitative
analyses of these data are presented below. Importantly, omission
of the primary antibody eliminated immunoreactivity in these
WT animals (data not shown).
To verify the specificity of p-trk IR in kindled mice, peptide
competition experiments were performed. Preincubation of
pY490 antibody with its phosphopeptide immunogen (300 nM)
eliminated p-trk IR in sections from kindled mice (Fig. 2, com-
pare A, C) and unstimulated controls (data not shown). Impor-
tantly, preincubation with the unphosphorylated form of peptide
490 had no effect on the immunoreactivity (Fig. 2, compare A, B).
Moreover, preincubation of pY490 antibody with either phospho-
or unphospho-peptides from other sites of the trk receptor, 674/
675 and 785, did not reduce p-trk IR (data not shown). Together,
the results from these competition experiments support the as-
sertion that the p-trk IR detected by antibody pY490 in wild-type
mice reflects the phosphorylated form of a trk receptor at a
tyrosine residue within a sequence similar to that of pY490 of
human trkA.
Analyses of brain regions outside the hippocampal formation in
unstimulated controls disclosed p-trk immunoreactivity in multi-
ple areas of forebrain, including neocortex, lateral habenula, and
some hypothalamic nuclei (data not shown). In contrast to the
hippocampal formation, no marked increases were noticed in any
of these regions after seizures evoked in WT mice. Thus, subse-
quent analyses were confined to the hippocampal formation in
these studies.
Reduction of seizure-induced increased phospho-trk
immunoreactivity in trkBshc mutant mice
Because the pY490 antibody can detect the phosphorylated ty-
rosine residue in trkA, trkB, or trkC (Segal et al., 1996), the
precise trk receptor undergoing phosphorylation in the hip-
Figure 2. Reduction of p-trk immunoreactivity by phosphopeptide but
not by nonphosphopeptide. Immunoreactivity to p-trk is shown in repre-
sentative coronal sections of hippocampus from a WT mouse killed 24 hr
after a kindled seizure in which pY490 antibody is coincubated with the
following: A, no peptide; B, 300 nM nonphosphorylated form of peptide
490; C, 300 nM phosphorylated form of peptide 490. Scale bar, 650 m.
Figure 1. Reduction of seizure-induced increase of p-trk immunoreactivity in trkB shc mutant mice. A, C, E, p-trk immunoreactivity in unstimulated
/, /, and / mice. Note the absence of detectable immunoreactivity in dentate hilus and CA3 stratum lucidum of hippocampus. B, D, F, p-trk
immunoreactivity in/, /, and / mice 24 hr after a seizure evoked by stimulation of right amygdala. Arrows denote immunoreactivity in dentate
hilus and stratum lucidum in stimulated / and / mice. Despite some differences in background among individual animals, no systematic variation
in background attributable to genotype or stimulation status was present (data not shown). Note that quantitation was controlled for individual
differences in background by use of a control region (corpus callosum) intrinsic to each section. Scale bar, 650 m.
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pocampus during epileptogenesis is uncertain. To determine
whether phosphorylation of trkB in particular accounts for the
increased immunoreactivity in the hippocampus during epilepto-
genesis, p-trk immunohistochemistry was performed in WT and
trkBshc mice, which were either not stimulated or were killed 1 d
after a stimulation-evoked seizure. As described in the preceding
section, a marked increase of p-trk IR was evident in stratum
lucidum and dentate hilus with a moderate increase in stratum
oriens of CA3 after a seizure evoked in WT mice (Fig. 1, compare
A, B). The trkBshc mutation reduced the seizure-evoked increase
of immunoreactivity. That is, seizures evoked in trkBshc null mice
triggered no significant increase of immunoreactivity in stratum
lucidum, dentate hilus, or stratum oriens of CA3 (Fig. 1, compare
B, F). Results with heterozygous trkBshc were intermediate be-
tween the WT and trkBshc nulls (Fig. 1, compare B, D, F, in
lucidum, dentate hilus, and stratum oriens of CA3).
The immunoreactivity within hippocampus was quantified in
distinct subregions (Fig. 3) and confirmed the findings evident by
visual inspection. First, analyses of WT mice confirmed the
spatially selective, twofold to threefold increase of phospho-trk
immunoreactivity in stratum lucidum, the dentate hilus, and hilus
border after a seizure compared with unstimulated controls (Fig.
4A,B). Significant ( p  0.05; ANOVA) increases of a smaller
magnitude were also evident in stratum oriens of CA3 (Fig. 4A).
In contrast, comparison of stimulated with unstimulated trkBshc
null mutants disclosed no significant seizure-induced increases of
immunoreactivity in stratum lucidum, the dentate hilus or hilus
border, or CA3 stratum oriens (Fig. 4A,B). In addition to the
above comparisons of unstimulated versus stimulated mice of a
given genotype, comparisons of seizure-treated mice of distinct
genotypes revealed significant increases of immunoreactivity in
the mossy fiber pathway and stratum oriens of CA3 in WT
compared with trkBshc null mutants (Fig. 4A,B). Similar analyses
of trkBshc heterozygotes disclosed results intermediate between
wild-type and null mutants, but no significant increases of immu-
noreactivity were detected in the mossy fiber pathway and stratum
oriens of CA3 after a kindled seizure compared with unstimu-
lated controls of the same genotype (Fig. 4A,B). Interestingly, the
increases of p-trk IR after seizures exhibited striking heteroge-
neity among the trkBshc heterozygotes (data described but not
shown). Robust staining was seen in three of nine heterozygous
mice after a seizure with intensity and distribution similar to WT
mice after a seizure. However, no detectable increase was evident
in four heterozygous mice and a slight increase in the remaining
two mice. Together, these quantitative analyses demonstrate that
substitution of phenylalanine for tyrosine at residue 515 of trkB
reduces the increased p-trk IR after limbic seizures.
Development and persistence of kindling in trkBshc
mutant mice
No significant differences in the development of kindling were
detected among WT (/), heterozygous, and null trkBshc mu-
tants, as evident in the following observations. First, the current
required to evoke an afterdischarge (i.e., EST) was similar in the
three groups (180.0  40.1 A for /, n  4; 151.1  22.6 A
for/, n 9; 180 24.8 A for/, n 8; mean SEM; p
0.05; one-way ANOVA). Second, no significant differences were
detected in the numbers of stimulations required to evoke the
initial clonic motor seizures (class 4 or greater) in WT (5.5  0.9
stimulations) compared with heterozygous (6.4  0.5) or null
(6.8  0.7) mutants. Third, no significant differences were found
in the numbers of stimulations required to evoke three consecu-
tive class 4 (or greater) seizures, the numbers of stimulations
being 9.8  1.5, 10.3  0.5, and 10.8  0.9 in WT, heterozygous,
and null mutants, respectively (Fig. 5A). Finally, no significant
Figure 3. Locations at which densitometric measures of p-trk immuno-
reactivity were performed: 1, strata radiatum; 2, lucidum; 3, oriens; 4,
deep hilus; 5, hilus-GCL border; 6, IML; 7, MML; 8, OML.
Figure 4. Quantitative analyses of p-trk immunoreactivity in hippocam-
pal subregions of stimulated and unstimulated WT, heterozygous, and
null (trkB shc) mutant mice. The data are the mean  SEM of the
percentage reduction in gray value in the given subregions compared with
corpus callosum (see Materials and Methods); high values reflect more
intense immunoreactivity. *p  0.05 compared with unstimulated WT
mice;  p  0.05 compared with kindled and stimulated WT mice
(one-way ANOVA with post hoc Bonferroni’s test).
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differences were noted in the duration of electrographic seizures
during kindling development among the three experimental
groups (Fig. 5B). In summary, kindling development appears to
proceed normally in trkBshc mutants.
To determine whether the Shc binding site of the trkB receptor
influenced the persistence of the hyperexcitability after comple-
tion of kindling, WT and trkB shc mutants were maintained for a
stimulation-free period of 2 weeks after kindling and then sub-
jected to a single stimulation. The stimulation evoked a general-
ized seizure in all animals from each of the three groups (/,
/, and /). There was no significant difference among the
groups in duration of electrographic seizure (41.5  8.1, 41.4 
4.0, and 35.4  2.1 sec, respectively) or seizure class (5.5  0.5,
5.8  0.2, and 5.3  0.2, respectively; p  0.05; one-way
ANOVA). Thus, the persistence of kindling was unaffected in the
trkBshc mutant mice.
DISCUSSION
Our previous ex vivo analyses of limbic epileptogenesis in rats
demonstrated increased pY490 immunoreactivity in the hip-
pocampal mossy fiber pathway, providing immunohistochemical
evidence for activation of trk receptor tyrosine kinase. Which trk
receptor(s) in particular accounted for the immunoreactivity was
unclear. To test the hypothesis that phosphorylation of trkB
contributed to the increased immunoreactivity, we studied mu-
tant mice (trkBshc) in which phenylalanine was substituted for
tyrosine at residue 515 of trkB, a site homologous to residue 490
of human trkA. Three principal findings emerge. First, the pre-
vious results in rats were confirmed and extended by the studies
of mice. A single, brief seizure induced by stimulation of the right
amygdala in a kindled mouse in a WT background induced
increased pY490 immunoreactivity bilaterally in the hippocampal
mossy fiber pathway. In addition, increased pY490 immunoreac-
tivity was evident in stratum oriens of CA3 bilaterally. Second, in
contrast to WT mice, seizures evoked in null mutant (trkBshc)
mice induced no significant increase of pY490 immunoreactivity
in either the mossy fiber pathway or CA3 stratum oriens. Third,
despite the reduction of the seizure-induced increase of pY490
immunoreactivity, the development and persistence of kindling
as measured by electrophysiological and behavioral indices did
not differ between trkBshc mutant and WT mice. These data
demonstrate that the neurotrophin receptor trkB undergoes phos-
phorylation in the mossy fiber pathway and CA3 stratum oriens of
the hippocampus during limbic epileptogenesis. In addition, the
signaling pathways activated by the Shc site of trkB exert no
detectable regulatory effects on limbic epileptogenesis.
The present study revealed that the increased p-trk immuno-
reactivity evident in the hippocampus during limbic epileptogen-
esis was reduced in trkBshc mutant mice, implying that phosphor-
ylation of trkB underlies the increased p-trk immunoreactivity.
Whether the increased p-trkB immunoreactivity is attributable to
a post-translational modification of a fixed number of constitu-
tively expressed trkB molecules, to post-translational modifica-
tion of increased numbers of trkB molecules, or some combina-
tion of the two is uncertain. The presence of the increased p-trk
immunoreactivity in WT mice adds to previous findings in rats
and demonstrates that trkB activation occurs during limbic epi-
leptogenesis in multiple species. Moreover, the induction of the
immunoreactivity by a single, brief seizure evoked in a kindled
mouse extends the previous studies using chemoconvulsant-
induced status epilepticus or massed electrical stimulations and
demonstrates that activation of trkB is common to limbic epilep-
togenesis induced by diverse methods. In light of evidence impli-
cating a causal role for trkB activation in limbic epileptogenesis
(Kokaia et al., 1995; Binder et al., 1999a; Croll et al., 1999;
La¨hteinen et al., 2002), knowing where and when trkB activation
occurs will facilitate elucidating its structural and functional con-
sequences and, in turn, provide insight into mechanisms of limbic
epileptogenesis.
The light microscopic distribution provides a clue to the cellu-
lar localization of the increased p-trkB immunoreactivity. Its
presence in the dentate hilus and stratum lucidum of CA3 corre-
sponds to the mossy fiber axons of the dentate granule cells,
providing the most parsimonious explanation for its cellular lo-
calization. Whereas our studies of rats disclosed increased p-trk
immunoreactivity confined to the mossy fiber pathway (Binder et
al., 1999b), the present study revealed increased p-trkB immuno-
reactivity not only in the mossy fiber pathway but also throughout
Figure 5. Behavioral (A) and electrographic seizure ( B) measures of
kindling development in WT and trkB shc mutant mice. Kindling develop-
ment is presented as behavioral seizure class (A) and electrographic
seizure duration as a function of the number of stimulations that evoked
electrographic seizures ( y-axis). Wild type (/; n  4), heterozygous
(/; n 9), and homozygous (/; n 8) mutant mice. ADD# (x-axis)
refers to the number of stimulations that evoked an afterdischarge with
duration of at least 5 sec. Data are mean  SEM. Note that neither
seizure class nor electrographic seizure duration was significantly differ-
ent among the three groups (one-way ANOVA).
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stratum oriens of CA3 extending to the junction with CA2 (Fig.
1B). Whether this p-trkB immunoreactivity is localized to an
infrapyramidal projection of mossy fibers, axons of CA3 pyrami-
dal cells, and/or postsynaptic targets such as interneurons or
basilar dendrites of CA3 pyramidal cells is uncertain. Ultrastruc-
tural studies will be required to establish the cellular locale of the
p-trkB immunoreactivity in both the mossy fiber pathway and
stratum oriens of CA3.
Circumstantial evidence implicates increased release of BDNF
as the proximate cause for the increased p-trkB immunoreactivity
during limbic epileptogenesis. The binding of neurotrophin to the
trk receptor induces dimerization and trans-autophosphorylation
of a subset of tyrosine residues (Schlessinger and Ullrich, 1992;
Guiton et al., 1994), thereby suggesting that the binding of a
neurotrophin to trkB underlies its increased phosphorylation. The
occurrence of the increased p-trkB immunoreactivity after sei-
zures suggests the possibility that seizures induced increased ex-
pression of a neurotrophin that is translated, transported, released,
and thereby activates trkB. Analysis of the temporal and spatial
patterns of seizure-mediated regulation of neurotrophins supports
the candidacy of BDNF. The seizure-induced increase of BDNF
protein peaks at24 hr, the time point corresponding to increased
p-trkB immunoreactivity (Nawa et al., 1995; Elme´r et al., 1998;
Rudge et al., 1998; Binder et al., 1999b). Concordance of the
anatomic distribution of seizure-induced increases of BDNF and
the p-trkB immunoreactivity further implicate BDNF; that is,
immunohistochemical studies disclosed increased BDNF in the
granule cell soma within 2 hr after seizures and in the mossy fiber
pathway 1 to 2 d thereafter (Yan et al., 1997; Vezzani et al., 1999).
We favor the idea that BDNF is anterogradely transported to the
mossy fiber axons (Conner et al., 1997; Smith et al., 1997), from
which it is released and activates trkB on the mossy fibers by a
paracrine or autocrine mechanism. Concordance of the anatomic
distribution of seizure-induced BDNF (Yan et al., 1997, their Fig.
7D) and p-trkB immunoreactivity in stratum oriens of CA3 im-
plicates BDNF in this site as well. Together with persistence of
seizure-induced p-trk immunoreactivity in NT-4 null mutants
(He et al., 1999), this circumstantial evidence favors BDNF as the
neurotrophin activating p-trkB in hippocampus.
What consequence(s) of trkB activation, presumably by BDNF,
might contribute to the increased excitability evident as limbic
epileptogenesis? The fact that at least part of the increased p-trkB
immunoreactivity may reside in dentate granule cells refines the
question: what functional and structural consequences of en-
hanced activation of trkB in granule cells by BDNF might pro-
mote increased hippocampal excitability? The fact that activation
of trkB by BDNF can enhance excitatory synaptic transmission
(Lohof et al., 1993; Kang and Schuman, 1995; Levine et al., 1995,
Stoop and Poo, 1996) and reduce inhibitory synaptic transmission
(Tanaka et al., 1997) in hippocampus raises the interesting pos-
sibility that enhanced synaptic activation of CA3 pyramidal cells
by mossy fibers, either directly or indirectly by disinhibition of the
mossy fiber–interneuron–CA3 pyramidal cell circuit is one con-
sequence of trkB activation. The increased excitability of CA3
pyramidal cells in kindled animals as detected by increased epi-
leptiform bursting induced by elevated K or lowered Mg2 in
isolated hippocampal slices (King et al., 1985; Behr et al., 1998) is
consistent with this idea. Another possibility relates to the in-
creased recurrent excitatory synapses that have been identified
among dentate granule cells in the epileptic brain, synapses that
would be expected to promote repetitive firing of the granule cells
in response to an isolated excitatory synaptic input (Wuarin and
Dudek, 2001). Two distinct morphological plasticities of the gran-
ule cells have been identified in the epileptic brain, either of which
could underlie increased recurrent excitatory synapses: sprouting
of the mossy fiber axons and formation of basal dendrites (Nadler
et al., 1980; Spigelman et al., 1998). We found that particle-
mediated gene transfer of BDNF, but not NGF, into the dentate
granule cells in hippocampal explant cultures is sufficient to
induce increases in both axonal branching and basilar dendrite
number (Danzer et al., 2001). Whether BDNF-mediated activa-
tion of trkB during limbic epileptogenesis in vivo mediates these
functional and/or structural effects remains to be elucidated.
Despite the evidence that trkB activation promotes limbic
epileptogenesis, the signaling pathways mediating the epilepto-
genic consequences of trkB activation are obscure. After binding
a ligand, trk receptors autophosphorylate on cytoplasmic tyrosine
residues, which themselves become docking sites for intracellular
signaling proteins. Shc adaptor proteins associate directly with a
specific site in trk receptors and activate a signaling pathway
involving Ras, Raf, MAPK1 [for mitogen-activated protein
(MAP) kinase 1], MAPK2, Mek 1 (for MAP kinase kinase 1),
and Mek 2, one consequence of which is activation of transcrip-
tion factors and regulation of gene expression. The present stud-
ies reveal that introduction of the Y515F mutation into the
germline of the trkBshc/shc mice did not modify either electrophys-
iological or behavioral indices of epileptogenesis, despite previ-
ous evidence that BDNF- and NT-4-mediated activation of
ERKs (for extracellular signal-regulated kinase) were attenuated
in neurons isolated from Shc mutant mice (Minichiello et al.,
1998). These results imply that trkB-mediated activation of the
Ras/ERK pathway does not mediate epileptogenesis or that this
pathway is redundant with other pathways, such as phospholipase
C pathway. The absence of detectable differences in epilepto-
genesis between WT and trkB shc/shc is reminiscent of the absence
of detectable differences in long-term potentiation between WT
and trkBshc/shc mice (Korte et al., 2000), despite defects in long-
term potentiation in BDNF and trkB null mutant mice (Korte et
al., 1995; Minichiello et al., 1999; Xu et al., 2000). The trkB
signaling pathways mediating epileptogenesis remain elusive, and
solving this question will require the generation of additional
signaling alleles of the trkB gene.
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